|
KMID : 0603820140200040227
|
|
Journal of Experimental & Biomedical Science
2014 Volume.20 No. 4 p.227 ~ p.236
|
|
|
Gingko biloba Extract Ameliorates Colonic Inflammation in DSS-induced Model of Colitis in Mice
|
|
Rhee Ki-Jong
Gwon Sun-Yeong
Hwang Soon-Jae
Lee Chang-Gun
Jang In-Ho
Wie Myung-Bok
Jung Bae-Dong
|
|
|
Abstract
|
|
|
|
Ulcerative colitis (UC) is a serious gastrointestinal tract disease characterized by recurrent chronic inflammation and mucosal damage of the gastrointestinal tract. The conventional therapies of choice are anti-inflammatory agents, steroids and anti-TNF-α therapy. However, inherent limitations in these therapies have steered many UC patients to supplement existing therapies with alternative medicinal products. In the current study, we tested the efficacy of Gingko bilola extract (EGb 761) in abating colonic inflammation in a DSS-induced murine model of colitis. C57BL/6 mice were administered 2% DSS in the drinking water for 7 days, then regular water for 7 days, and then 2% DSS for an additional 7 days. EGb 761 (1 mg/dose) was oral gavaged daily for the duration of the experiment. At the termination of the experiment, mice treated with EGb+DSS showed higher body weight, lower spleen weight and longer colon length compared to mice treated with DSS alone. HE-stained colon tissues also exhibited less histologic inflammation in mice treated with EGb+ DSS mice compared to mice treated with DSS alone. The serum levels inflammatory cytokines, KC and TNF-α, were also decreased in mice treated with EGb+DSS compared to mice treated with DSS alone. Finally, addition of EGb 761 to TNF-α treated colonic cell line (HT29/c1) decreased secretion of IL-8 in vitro. These results collectively suggest that EGb 761 abates induction of colitis in DSS-induced model of colitis in mice.
|
|
|
KEYWORD
|
|
|
Gingko, Colitis, Dextran sulfate sodium, TNF-α, KC
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|